The Department of Obstetrics and Gynecology at Indiana University School of Medicine is ranked No. 11 for funding from the National Institutes of Health, and faculty member Sara Quinney, PhD, is the fifth highest-funded researcher in an OB-GYN department nationally, according to data compiled by the Blue Ridge Institute for Medical Research.
IU School of Medicine researchers received more than $214.8 million in total funding from the National Institutes of Health during federal fiscal year 2022, making the school the No. 14 NIH-funded public medical school in the country.
IU’s Department of OB-GYN is ranked No. 11 among NIH-funded OB-GYN department, with $6,311,600. That makes it one of five departments at IU School of Medicine with rankings in the top 15, and one of 11 departments with ranking in the top 25.
Quinney’s research funding totaled $4,377,865 in 2022, making her the fifth highest-funded researcher in an OB-GYN department in the nation, according to the Blue Ridge Institute for Medical Research.
IU School of Medicine uses Blue Ridge Institute for Medical Research rankings instead of internally calculating rankings based on NIH funding data. An independent, nonprofit organization, Blue Ridge has published rankings of medical schools, departments and investigators since 2006 and is widely considered the industry standard for U.S. medical school rankings. Data are compiled and released annually shortly after the federal fiscal year ends.
Faculty investigators in the Department of Obstetrics and Gynecology conduct collaborative research across a broad spectrum of women’s health issues. Investigators have been awarded numerous highly competitive grants from a variety of funding agencies, including the NIH, and have published results from these various projects in several high impact peer-reviewed journals. In addition, some of the research findings here have contributed to practice changes worldwide in women’s health.
Quinney’s work utilizes in vitro bench-based wet lab studies, in vivo clinical studies, and in silico pharmacokinetic models to better understand factors influencing drug pharmacokinetics and response. Her work focuses largely on the individualization of drug therapy in special populations, and especially in understanding of changes in drug metabolism and pharmacokinetics in pregnancy. She is involved in several studies examining drugs such as methadone, betamethasone, and misoprostol in pregnant women.
Quinney is currently an assistant professor in the Department of Obstetrics and Gynecology, where she is a member of PREGMED, the Indiana University Signature Center for Pharmacogenetics and Therapeutics Research in Maternal and Child Health.
She is also a member of the Institute of Personalized Medicine and the Center for Computational Biology and Bioinformatics at IUSM and the Associate Director of the Indiana CTSI’s Disease and Therapeutic Response Modeling Program. Quinney is the also the principal investigator of the Maternal and Pediatric Precision in Therapeutics (MPRINT) Hub’s Data, Model, Knowledge, and Research Coordination Center (DMKRCC), serving as co-leader of the Pharmacometrics and Clinical Trial Design Core.
